You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康健國際醫療(03886.HK)預期中期溢利約2520萬至3960萬港元
格隆匯 08-12 18:46

格隆匯8月12日丨康健國際醫療(03886.HK)公佈,公司預期截至2025年6月30日止六個月將錄得介於約25,200,000港元至39,600,000港元的未經審核綜合溢利,當中包括介於約9,100,000港元至14,300,000港元的未經審核股東應占綜合溢利,而上年同期,則錄得未經審核綜合虧損約28,500,000港元,當中包括未經審核股東應占綜合虧損約47,700,000港元。

由未經審核綜合虧損扭虧為盈至未經審核綜合溢利乃主要由於以下各項的綜合影響:(i)期間錄得的集團投資物業的公平值虧損較上年同期減少;(ii)期間就集團於聯營公司的權益並無錄得減值虧損,而上年同期就集團於聯營公司的權益則錄得減值虧損;(iii)期間錄得集團應占聯營公司溢利,而上年同期則錄得應占聯營公司虧損;及(iv)期間錄得的集團毛利較上年同期減少。

倘排除於未經審核簡明綜合損益表中所示的「其他收益及虧損淨額」後,集團預期期間,就其業務經營將錄得介於約27,100,000港元至42,600,000港元的未經審核經營溢利,當中包括介於約11,000,000港元至17,300,000港元的未經審核股東應占經營溢利。集團仍正在對其相關資產進行評估及估值,待集團取得有關評估及估值的最終結果後,集團就期間的相關資產金額將可能作進一步調整。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account